Regarding Iodixanol for Pediatric CTA. Comment on Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. <i>Children</i> 2021, <i>8</i>, 949
With interest, we read the publication ‘Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320′ by Pop [...]
Main Authors: | Ulf Nyman, Peter Aspelin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/9/5/696 |
Similar Items
-
Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320
by: Marian Pop
Published: (2021-10-01) -
Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. <i>Children</i> 2021, <i>8</i>, 949”
by: Marian Pop
Published: (2022-05-01) -
Deconvolution Analysis of the Non-Ionic Iomeprol, Iobitridol and Iodixanol Contrast Media-Treated Human Whole Blood Thermograms: A Comparative Study
by: Elek Telek, et al.
Published: (2023-07-01) -
Nephrotoxicity of iodixanol versus iopamidol in patients with acute coronary syndrome
by: Mehmet Gül, et al.
Published: (2013-02-01) -
Efficacy and Safety of Iodixanol in Computed Coronary Tomographic Angiography and Cardiac Catheterization
by: Matthew J. Budoff, et al.
Published: (2023-10-01)